Clinical Trial Update: Enstilar in Combination With Biologic Agents [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Enstilar in combination with biologic agents for psoriasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Enstilar (calcipotriene; betamethasone dipropionate)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Psoriasis | Phase 4 | Status: COMPLETED